IST:BIOEN Statistics

Total Valuation

IST:BIOEN has a market cap or net worth of TRY 7.75 billion. The enterprise value is 11.58 billion.

Market Cap	7.75B
Enterprise Value	11.58B

Important Dates

The last earnings date was Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	n/a

Share Statistics

IST:BIOEN has 500.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	500.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+5.47%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	20.64%
Float	227.56M

Valuation Ratios

The trailing PE ratio is 15.70.

PE Ratio	15.70
Forward PE	n/a
PS Ratio	4.20
PB Ratio	2.04
P/TBV Ratio	2.23
P/FCF Ratio	6.39
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 56.06, with an EV/FCF ratio of 9.55.

EV / Earnings	23.45
EV / Sales	6.27
EV / EBITDA	56.06
EV / EBIT	n/a
EV / FCF	9.55

Financial Position

The company has a current ratio of 0.45, with a Debt / Equity ratio of 1.02.

Current Ratio	0.45
Quick Ratio	0.17
Debt / Equity	1.02
Debt / EBITDA	28.64
Debt / FCF	3.28
Interest Coverage	-0.79

Financial Efficiency

Return on equity (ROE) is 22.42% and return on invested capital (ROIC) is -3.79%.

Return on Equity (ROE)	22.42%
Return on Assets (ROA)	-3.50%
Return on Invested Capital (ROIC)	-3.79%
Return on Capital Employed (ROCE)	-5.90%
Revenue Per Employee	2.58M
Profits Per Employee	691,448
Employee Count	792
Asset Turnover	0.30
Inventory Turnover	5.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.88% in the last 52 weeks. The beta is -0.02, so IST:BIOEN's price volatility has been lower than the market average.

Beta (5Y)	-0.02
52-Week Price Change	-22.88%
50-Day Moving Average	15.97
200-Day Moving Average	17.96
Relative Strength Index (RSI)	46.48
Average Volume (20 Days)	2,733,797

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:BIOEN had revenue of TRY 1.85 billion and earned 493.69 million in profits. Earnings per share was 0.99.

Revenue	1.85B
Gross Profit	149.40M
Operating Income	-348.78M
Pretax Income	58.08M
Net Income	493.69M
EBITDA	52.95M
EBIT	-348.78M
Earnings Per Share (EPS)	0.99

Full Income Statement

Balance Sheet

The company has 159.85 million in cash and 3.97 billion in debt, giving a net cash position of -3.81 billion or -7.63 per share.

Cash & Cash Equivalents	159.85M
Total Debt	3.97B
Net Cash	-3.81B
Net Cash Per Share	-7.63
Equity (Book Value)	3.91B
Book Value Per Share	7.61
Working Capital	-1.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -137.56 million, giving a free cash flow of 1.21 billion.

Operating Cash Flow	1.35B
Capital Expenditures	-137.56M
Free Cash Flow	1.21B
FCF Per Share	2.42

Full Cash Flow Statement

Margins

Gross margin is 8.10%, with operating and profit margins of -18.90% and 26.75%.

Gross Margin	8.10%
Operating Margin	-18.90%
Pretax Margin	3.15%
Profit Margin	26.75%
EBITDA Margin	2.87%
EBIT Margin	-18.90%
FCF Margin	65.68%

Dividends & Yields

IST:BIOEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	6.37%
FCF Yield	15.64%

Stock Splits

The last stock split was on November 24, 2021. It was a forward split with a ratio of 3.3333333.

Last Split Date	Nov 24, 2021
Split Type	Forward
Split Ratio	3.3333333

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a